Priority Date: 17.02.12 (EP 20120305187)

NEW METHOD FOR PROGNOSING THE SURVIVAL OF PATIENTS SUFFERING FROM CHRONIC MYELOMONOCYTIC LEUKAEMIA

  • Application ID: EP13707823
  • Status: PATENT GRANTED

Applicants

Technology company logo small
Technology Company

Attorney

Employment test 201 - 500 employees
Company dna regimbeau
operating since 1931
Headquarter in Paris and 8 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Cabinet Regimbeau is specialized in C12. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 17.02.2012 - Priority Date (EP 20120305187)
  • 22.08.2013 - Publication A1 (WO2013121048)
  • 24.12.2014 - Publication A1 (EP2814982)
  • 05.10.2016 - Publication B1 (EP2814982)
  • 22.02.2017 - Publication B9 (EP2814982)

IPC Classification